N-(4-hydroxyphenyl)retinamide activation of a distinct pathway signaling apoptosis.
Dmitrovsky
E
E
D016588:Anticarcinogenic Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D005260:Female; D017313:Fenretinide / Q000494:pharmacology*; D005609:Free Radicals; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*; D010100:Oxygen / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000503:physiopathology
D016588:Anticarcinogenic Agents; D000970:Antineoplastic Agents; D005609:Free Radicals; D017313:Fenretinide; D010100:Oxygen